Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Lysyl oxidases: linking structures and immunity in the tumor microenvironment

P. Tenti, L. Vannucci,

. 2020 ; 69 (2) : 223-235. [pub] 20191025

Language English Country Germany

Document type Journal Article, Review

Grant support
1560843 Generali/Ceska Pojistovna Foundation
1560804 UniCredit Bank a.s. CZ

E-resources Online Full text

NLK PubMed Central from 1982
ProQuest Central from 1997-03-01 to 1 year ago
Medline Complete (EBSCOhost) from 2000-04-01 to 1 year ago
Health & Medicine (ProQuest) from 1997-03-01 to 1 year ago
Public Health Database (ProQuest) from 1997-03-01 to 1 year ago

The lysyl oxidases (LOXs) are a family of enzymes deputed to cross-link collagen and elastin, shaping the structure and strength of the extracellular matrix (ECM). However, many novel "non-canonical" functions, alternative substrates, and regulatory mechanisms have been described and are being continuously elucidated. The activity of LOXs, therefore, appears to be integrated into a complex network of signals regulating many cell functions, including survival/proliferation/differentiation. Among these signaling pathways, TGF-β and PI3K/Akt/mTOR, in particular, cross-talk extensively with each other and with LOXs also initiating complex feedback loops which modulate the activity of LOXs and direct the remodeling of the ECM. A growing body of evidence indicates that LOXs are not only important in the homeostasis of the normal structure of the ECM, but are also implicated in the establishment and maturation of the tumor microenvironment. LOXs' association with advanced and metastatic cancer is well established; however, there is enough evidence to support a significant role of LOXs in the transformation of normal epithelial cells, in the accelerated tumor development and the induction of invasion of the premalignant epithelium. A better understanding of LOXs and their interactions with the different elements of the tumor immune microenvironment will prove invaluable in the design of novel anti-tumor strategies.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20005760
003      
CZ-PrNML
005      
20200522094623.0
007      
ta
008      
200511s2020 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00262-019-02404-x $2 doi
035    __
$a (PubMed)31650200
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Tenti, Paolo $u Laboratory of Immunotherapy, Institute of Microbiology of the Czech Academy of Sciences, Videnska 1083, 142 20, Prague 4, Czech Republic. Faculty of Science, Charles University, Albertov 6, 128 00, Prague, Czech Republic.
245    10
$a Lysyl oxidases: linking structures and immunity in the tumor microenvironment / $c P. Tenti, L. Vannucci,
520    9_
$a The lysyl oxidases (LOXs) are a family of enzymes deputed to cross-link collagen and elastin, shaping the structure and strength of the extracellular matrix (ECM). However, many novel "non-canonical" functions, alternative substrates, and regulatory mechanisms have been described and are being continuously elucidated. The activity of LOXs, therefore, appears to be integrated into a complex network of signals regulating many cell functions, including survival/proliferation/differentiation. Among these signaling pathways, TGF-β and PI3K/Akt/mTOR, in particular, cross-talk extensively with each other and with LOXs also initiating complex feedback loops which modulate the activity of LOXs and direct the remodeling of the ECM. A growing body of evidence indicates that LOXs are not only important in the homeostasis of the normal structure of the ECM, but are also implicated in the establishment and maturation of the tumor microenvironment. LOXs' association with advanced and metastatic cancer is well established; however, there is enough evidence to support a significant role of LOXs in the transformation of normal epithelial cells, in the accelerated tumor development and the induction of invasion of the premalignant epithelium. A better understanding of LOXs and their interactions with the different elements of the tumor immune microenvironment will prove invaluable in the design of novel anti-tumor strategies.
650    _2
$a zvířata $7 D000818
650    _2
$a biologické markery $7 D015415
650    _2
$a extracelulární matrix $x genetika $x metabolismus $7 D005109
650    _2
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a lidé $7 D006801
650    12
$a imunita $7 D007109
650    _2
$a multigenová rodina $7 D005810
650    _2
$a nádory $x etiologie $x patologie $7 D009369
650    _2
$a lysyloxidasa $x chemie $x imunologie $7 D008249
650    _2
$a signální transdukce $7 D015398
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    _2
$a nádorové mikroprostředí $x imunologie $7 D059016
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Vannucci, Luca $u Laboratory of Immunotherapy, Institute of Microbiology of the Czech Academy of Sciences, Videnska 1083, 142 20, Prague 4, Czech Republic. vannucci@biomed.cas.cz.
773    0_
$w MED00001041 $t Cancer immunology, immunotherapy : CII $x 1432-0851 $g Roč. 69, č. 2 (2020), s. 223-235
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31650200 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200522094621 $b ABA008
999    __
$a ok $b bmc $g 1524618 $s 1095816
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 69 $c 2 $d 223-235 $e 20191025 $i 1432-0851 $m Cancer immunology and immunotherapy $n Cancer Immunol Immunother $x MED00001041
GRA    __
$a 1560843 $p Generali/Ceska Pojistovna Foundation
GRA    __
$a 1560804 $p UniCredit Bank a.s. CZ
LZP    __
$a Pubmed-20200511

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...